| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTB
|
actin, beta
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADHFE1
|
alcohol dehydrogenase, iron containing, 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AEN
|
apoptosis enhancing nuclease
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1
|
|
ALKBH4
|
alkB, alkylation repair homolog 4 (E. coli)
|
|
AMOT
|
angiomotin
|
|
AMOTL1
|
angiomotin like 1
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle)
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA6
|
annexin A6
|
|
API5
|
apoptosis inhibitor 5
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARFGAP1
|
ADP-ribosylation factor GTPase activating protein 1
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
|
ARL8B
|
ADP-ribosylation factor-like 8B
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ARTN
|
artemin
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATRAID
|
all-trans retinoic acid-induced differentiation factor
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXIN1
|
axin 1
|
|
B2M
|
beta-2-microglobulin
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BICD1
|
bicaudal D homolog 1 (Drosophila)
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLMH
|
bleomycin hydrolase
|
|
BMF
|
Bcl2 modifying factor
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C1RL
|
complement component 1, r subcomponent-like
|
|
C3
|
complement component 3
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACYBP
|
calcyclin binding protein
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CARTPT
|
CART prepropeptide
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBX1
|
chromobox homolog 1
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNG2
|
cyclin G2
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD1E
|
CD1e molecule
|
|
CD247
|
CD247 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD9
|
CD9 molecule
|
|
CD96
|
CD96 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC14B
|
cell division cycle 14B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEP192
|
centrosomal protein 192kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHCHD4
|
coiled-coil-helix-coiled-coil-helix domain containing 4
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRDL2
|
chordin-like 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLDN1
|
claudin 1
|
|
CLIC3
|
chloride intracellular channel 3
|
|
CLMP
|
CXADR-like membrane protein
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CLOCK
|
clock circadian regulator
|
|
CMA1
|
chymase 1, mast cell
|
|
CMIP
|
c-Maf inducing protein
|
|
CMYA5
|
cardiomyopathy associated 5
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COLEC11
|
collectin sub-family member 11
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPA
|
coatomer protein complex, subunit alpha
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CST3
|
cystatin C
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CUL3
|
cullin 3
|
|
CUL4A
|
cullin 4A
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2U1
|
cytochrome P450, family 2, subfamily U, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAXX
|
death-domain associated protein
|
|
DBN1
|
drebrin 1
|
|
DBNL
|
drebrin-like
|
|
DCK
|
deoxycytidine kinase
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFB103B
|
defensin, beta 103B
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLX3
|
distal-less homeobox 3
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DNM2
|
dynamin 2
|
|
DOCK7
|
dedicator of cytokinesis 7
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSTN
|
destrin (actin depolymerizing factor)
|
|
DTNA
|
dystrobrevin, alpha
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
DUSP7
|
dual specificity phosphatase 7
|
|
DYM
|
dymeclin
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR3
|
early growth response 3
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENDOG
|
endonuclease G
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA1
|
EPH receptor A1
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETFB
|
electron-transfer-flavoprotein, beta polypeptide
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM161A
|
family with sequence similarity 161, member A
|
|
FAM20A
|
family with sequence similarity 20, member A
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBN1
|
fibrillin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FERMT1
|
fermitin family member 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGG
|
fibrinogen gamma chain
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FLG
|
filaggrin
|
|
FLG2
|
filaggrin family member 2
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMNL1
|
formin-like 1
|
|
FN1
|
fibronectin 1
|
|
FNBP1
|
formin binding protein 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA6
|
GATA binding protein 6
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GDF11
|
growth differentiation factor 11
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLIPR2
|
GLI pathogenesis-related 2
|
|
GLTP
|
glycolipid transfer protein
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GON4L
|
gon-4-like (C. elegans)
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN3B
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
H3F3A
|
H3 histone, family 3A
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAS1
|
hyaluronan synthase 1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNMT
|
histamine N-methyltransferase
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HOMER1
|
homer scaffolding protein 1
|
|
HOXC9
|
homeobox C9
|
|
HPSE
|
heparanase
|
|
HRH2
|
histamine receptor H2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFNA1
|
interferon, alpha 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL2
|
interleukin 2
|
|
IL25
|
interleukin 25
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KAZN
|
kazrin, periplakin interacting protein
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1191
|
KIAA1191
|
|
KIF1C
|
kinesin family member 1C
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF3
|
Kruppel-like factor 3 (basic)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT7
|
keratin 7, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LOX
|
lysyl oxidase
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
LYST
|
lysosomal trafficking regulator
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCOLN1
|
mucolipin 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MEP1B
|
meprin A, beta
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP4
|
microfibrillar-associated protein 4
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MIA
|
melanoma inhibitory activity
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR100
|
microRNA 100
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR132
|
microRNA 132
|
|
MIR134
|
microRNA 134
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR184
|
microRNA 184
|
|
MIR203A
|
microRNA 203a
|
|
MIR21
|
microRNA 21
|
|
MIR224
|
microRNA 224
|
|
MIR23B
|
microRNA 23b
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR571
|
microRNA 571
|
|
MIR652
|
microRNA 652
|
|
MIR99A
|
microRNA 99a
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH3
|
mutL homolog 3
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP23A
|
matrix metallopeptidase 23A (pseudogene)
|
|
MMP23B
|
matrix metallopeptidase 23B
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MORC2
|
MORC family CW-type zinc finger 2
|
|
MPO
|
myeloperoxidase
|
|
MPST
|
mercaptopyruvate sulfurtransferase
|
|
MPZ
|
myelin protein zero
|
|
MS4A12
|
membrane-spanning 4-domains, subfamily A, member 12
|
|
MSH5
|
mutS homolog 5
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MSTN
|
myostatin
|
|
MT1A
|
metallothionein 1A
|
|
MT1E
|
metallothionein 1E
|
|
MTA1
|
metastasis associated 1
|
|
MTCH2
|
mitochondrial carrier 2
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH3
|
myosin, heavy chain 3, skeletal muscle, embryonic
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1A
|
myosin IA
|
|
MYO1B
|
myosin IB
|
|
MYO1C
|
myosin IC
|
|
NADK2
|
NAD kinase 2, mitochondrial
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCBP1
|
nuclear cap binding protein subunit 1, 80kDa
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDRG2
|
NDRG family member 2
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEK9
|
NIMA-related kinase 9
|
|
NELFCD
|
negative elongation factor complex member C/D
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NFASC
|
neurofascin
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRX1
|
NLR family member X1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOVA1
|
neuro-oncological ventral antigen 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRTN
|
neurturin
|
|
NRXN1
|
neurexin 1
|
|
NRXN3
|
neurexin 3
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
OLFM3
|
olfactomedin 3
|
|
OLFML2A
|
olfactomedin-like 2A
|
|
OLFML3
|
olfactomedin-like 3
|
|
OLIG1
|
oligodendrocyte transcription factor 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OR2AT4
|
olfactory receptor, family 2, subfamily AT, member 4
|
|
OSM
|
oncostatin M
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PARD6B
|
par-6 family cell polarity regulator beta
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast)
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PCM1
|
pericentriolar material 1
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD5
|
programmed cell death 5
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER2
|
period circadian clock 2
|
|
PF4
|
platelet factor 4
|
|
PF4V1
|
platelet factor 4 variant 1
|
|
PHB
|
prohibitin
|
|
PHB2
|
prohibitin 2
|
|
PHF1
|
PHD finger protein 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP3
|
plakophilin 3
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4E
|
phospholipase A2, group IVE
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD2
|
phospholipase D2
|
|
PLEK
|
pleckstrin
|
|
PLEKHH2
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
|
|
PLP2
|
proteolipid protein 2 (colonic epithelium-enriched)
|
|
PLTP
|
phospholipid transfer protein
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PNKP
|
polynucleotide kinase 3'-phosphatase
|
|
POC1A
|
POC1 centriolar protein A
|
|
POC1B
|
POC1 centriolar protein B
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PON1
|
paraoxonase 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R10
|
protein phosphatase 1, regulatory subunit 10
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREP
|
prolyl endopeptidase
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKD1
|
protein kinase D1
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PROKR2
|
prokineticin receptor 2
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PSPN
|
persephin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTN
|
pleiotrophin
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTX3
|
pentraxin 3, long
|
|
PUM2
|
pumilio RNA-binding family member 2
|
|
PVR
|
poliovirus receptor
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51D
|
RAD51 paralog D
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALGPS1
|
Ral GEF with PH domain and SH3 binding motif 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP9
|
RAN binding protein 9
|
|
RASL11B
|
RAS-like, family 11, member B
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBM4
|
RNA binding motif protein 4
|
|
RD3
|
retinal degeneration 3
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RGN
|
regucalcin
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOD
|
ras homolog family member D
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RLN1
|
relaxin 1
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RND3
|
Rho family GTPase 3
|
|
RNF213
|
ring finger protein 213
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPA4
|
replication protein A4, 30kDa
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SAR1B
|
secretion associated, Ras related GTPase 1B
|
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGN
|
secretagogin, EF-hand calcium binding protein
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SENP6
|
SUMO1/sentrin specific peptidase 6
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SF3B2
|
splicing factor 3b, subunit 2, 145kDa
|
|
SF3B4
|
splicing factor 3b, subunit 4, 49kDa
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SKI
|
SKI proto-oncogene
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC38A8
|
solute carrier family 38, member 8
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC51A
|
solute carrier family 51, alpha subunit
|
|
SLC51B
|
solute carrier family 51, beta subunit
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1
|
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNAPIN
|
SNAP-associated protein
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SNX17
|
sorting nexin 17
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SP100
|
SP100 nuclear antigen
|
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPHKAP
|
SPHK1 interactor, AKAP domain containing
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPN
|
sialophorin
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR2A
|
small proline-rich protein 2A
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRFBP1
|
serum response factor binding protein 1
|
|
SRGN
|
serglycin
|
|
ST13
|
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAB1
|
stabilin 1
|
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
STX8
|
syntaxin 8
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SWAP70
|
SWAP switching B-cell complex 70kDa subunit
|
|
TACC1
|
transforming, acidic coiled-coil containing protein 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAGLN
|
transgelin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX5
|
T-box 5
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TEFM
|
transcription elongation factor, mitochondrial
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THG1L
|
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TM4SF5
|
transmembrane 4 L six family member 5
|
|
TMEM173
|
transmembrane protein 173
|
|
TMF1
|
TATA element modulatory factor 1
|
|
TMPRSS11D
|
transmembrane protease, serine 11D
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TOX4
|
TOX high mobility group box family member 4
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPD52
|
tumor protein D52
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM3
|
tropomyosin 3
|
|
TPPP3
|
tubulin polymerization-promoting protein family member 3
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TXN
|
thioredoxin
|
|
TXN2
|
thioredoxin 2
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBD
|
ubiquitin D
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE4A
|
ubiquitination factor E4A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
UNC119
|
unc-119 homolog (C. elegans)
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
UTS2
|
urotensin 2
|
|
UTS2B
|
urotensin 2B
|
|
VAMP4
|
vesicle-associated membrane protein 4
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VASH1
|
vasohibin 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCL
|
vinculin
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WDR82
|
WD repeat domain 82
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
ZAR1
|
zygote arrest 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB2
|
zinc finger and BTB domain containing 2
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF804A
|
zinc finger protein 804A
|
